内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Singleton Mark Leonard. Insider active across 1 company, notably Bioventus Inc.. Aggregated, 21 filings have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €395k. Activity tracked since 24 March 2023. The latest transaction was filed on 10 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Singleton Mark Leonard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
13,000 股0Class A Common StockSEC:0001914936-26-000009:0
5,648 股@ US$9.060.0088% mcap10.0% 占其流量Class A Common StockSEC:0001914936-26-000009:1
18,625 股0Class A Common StockSEC:0001914936-26-000007:0
13,500 股0Class A Common StockSEC:0001914936-26-000004:0
3,875 股@ US$7.575.9% 占其流量Class A Common StockSEC:0001578563-25-000219:0
13,000 股0Class A Common StockSEC:0001578563-25-000211:0
5,479 股@ US$9.7911.3% 占其流量Class A Common StockSEC:0001578563-25-000191:0
18,625 股0Class A Common StockSEC:0001578563-25-000187:0
6,498 股@ US$10.1914.4% 占其流量Class A Common StockSEC:0001578563-25-000121:0
20,153 股0Class A Common StockSEC:0001578563-25-000074:0
10,733 股@ US$10.5324.7% 占其流量Class A Common StockSEC:0001578563-24-000517:0
31,000 股0Class A Common StockSEC:0001578563-24-000508:0
9,219 股@ US$5.5710.9% 占其流量Class A Common StockSEC:0001578563-24-000326:0
31,000 股0Class A Common StockSEC:0001578563-24-000318:0
13,753 股@ US$5.8417.1% 占其流量Class A Common StockSEC:0001578563-24-000312:0
42,202 股0Class A Common StockSEC:0001578563-24-000302:0
4,000 股@ US$4.754.0% 占其流量Class A Common StockSEC:0001578563-24-000203:0
13,000 股Class A Common StockSEC:0001578563-24-000193:0
18,625 股Class A Common StockSEC:0001578563-24-000182:0
6,044 股@ US$1.271.6% 占其流量Class A Common StockSEC:0000899243-23-009758:0
18,625 股Class A Common StockSEC:0000899243-23-009522:0
About Singleton Mark Leonard
Singleton Mark Leonard is a declarant with 19 filings in total. Across the 19 sampled filings, all linked to Bioventus Inc., the reported transactions are sales for EUR 394573 between 2023-03-23 and 2026-04-14, with Levée d'options as the most frequent transaction nature.